SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 151 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2024. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $142,086 | -66.5% | 26,023 | -38.6% | 0.02% | -63.0% |
| Q1 2024 | $424,000 | +355.8% | 42,400 | +86.0% | 0.05% | +200.0% |
| Q4 2023 | $93,024 | +376.3% | 22,800 | +351.8% | 0.02% | +200.0% |
| Q3 2023 | $19,532 | +30.6% | 5,047 | +101.1% | 0.01% | +20.0% |
| Q2 2023 | $14,960 | +77.0% | 2,510 | -2.9% | 0.01% | +66.7% |
| Q1 2023 | $8,450 | +10.4% | 2,584 | +33.3% | 0.00% | 0.0% |
| Q4 2022 | $7,655 | -30.4% | 1,938 | +8.8% | 0.00% | -40.0% |
| Q3 2022 | $11,000 | – | 1,781 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 25,001,856 | $96,757,183 | 7.02% |
| Omega Fund Management, LLC | 843,750 | $3,265,313 | 3.00% |
| Crestline Management, LP | 3,365,624 | $13,024,965 | 1.52% |
| Trustees of Columbia University in the City of New York | 98,353 | $380,626 | 0.70% |
| Alphabet Inc. | 2,812,500 | $10,884,375 | 0.70% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,963,704 | $11,469,534 | 0.62% |
| Casdin Capital, LLC | 750,000 | $2,902,500 | 0.32% |
| PFM Health Sciences, LP | 1,244,139 | $4,814,818 | 0.23% |
| HARBOURVEST PARTNERS LLC | 137,694 | $532,876 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 540,250 | $2,091 | 0.18% |